Xinquan Wang

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 23

Top Venues

Nature communications

Journal of virology

Cell research

Nature

Tsinghua University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tsinghua University

China

Professor :: School of Life Sciences

Publications

Shuyuan Qiao, Xinquan Wang
Structural determinants of spike infectivity in bat SARS-like coronaviruses RsSHC014 and WIV1. Journal of virology 98 (8) (2024)
Shuyuan Qiao, Xinquan Wang
Structural determinants of spike infectivity in bat SARS-like coronaviruses RsSHC014 and WIV1. Journal of virology 98 (8) (2024)
Shuyuan Qiao, Xinquan Wang
Structural determinants of spike infectivity in bat SARS-like coronaviruses RsSHC014 and WIV1. Journal of virology 98 (8) (2024)
Shuyuan Qiao, Xinquan Wang
Structural determinants of spike infectivity in bat SARS-like coronaviruses RsSHC014 and WIV1. Journal of virology (2024)
Bin Ju, Qi Zhang, Ziyi Wang, Zhen Qin Aw, Peng Chen, Bing Zhou, Ruoke Wang, Xiangyang Ge, Qining Lv, Lin Cheng, Rui Zhang, Yi Hao Wong, Huixin Chen, Haiyan Wang, Sisi Shan, Xuejiao Liao, Xuanling Shi, Lei Liu, Justin Jang Hann Chu, Xinquan Wang, Zheng Zhang, Linqi Zhang
Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants. Nature immunology (2023)
Yubin Liu, Ziyi Wang, Xinyu Zhuang, Shengnan Zhang, Zhicheng Chen, Yan Zou, Jie Sheng, Tianpeng Li, Wanbo Tai, Jinfang Yu, Yanqun Wang, Zhaoyong Zhang, Yunfeng Chen, Liangqin Tong, Xi Yu, Linjuan Wu, Dong Chen, Renli Zhang, Ningyi Jin, Weijun Shen, Jin-Cun Zhao, Mingyao Tian, Xinquan Wang, Cheng Gong
Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants. Nature communications 14 (1) (2023)
Xiaoman Li, Yongbing Pan, Qiangling Yin, Zejun Wang, Sisi Shan, Laixing Zhang, Jinfang Yu, Yuanyuan Qu, Lina Sun, Fang Gui, Jia Lu, Zhaofei Jing, Wei Wu, Tao Huang, Xuanling Shi, Jiandong Li, Xinguo Li, Dexin Li, Shiwen Wang, Maojun Yang, Linqi Zhang, Kai Duan, Mifang Liang, Xiao Ming Yang, Xinquan Wang
Structural basis of a two-antibody cocktail exhibiting highly potent and broadly neutralizing activities against SARS-CoV-2 variants including diverse Omicron sublineages. Cell discovery 8 (1) (2022)
Shuyuan Qiao, Shuyuan Zhang, Jiwan Ge, Xinquan Wang
The spike glycoprotein of highly pathogenic human coronaviruses: structural insights for understanding infection, evolution and inhibition. FEBS open bio 12 (9) (2022)
Shuyuan Zhang, Qingtai Liang, Xin-Heng He, Chongchong Zhao, Wenlin Ren, Ziqing Yang, Ziyi Wang, Qiang Ding, Haiteng Deng, Tong Wang, Linqi Zhang, Xinquan Wang
Loss of Spike N370 glycosylation as an important evolutionary event for the enhanced infectivity of SARS-CoV-2. Cell research 32 (3) (2022)
Jun Lan, Xin-Heng He, Yifei Ren, Ziyi Wang, Huan Zhou, Shilong Fan, Chenyou Zhu, Dongsheng Liu, Bin Shao, Tie-Yan Liu, Qisheng Wang, Linqi Zhang, Jiwan Ge, Tong Wang, Xinquan Wang
Structural insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction. Cell research 32 (6) (2022)
Shuyuan Zhang, Shuyuan Qiao, Jinfang Yu, Jianwei Zeng, Sisi Shan, Long Tian, Jun Lan, Linqi Zhang, Xinquan Wang
Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution. Nature communications 12 (1) (2021)
Shihui Sun, Hongjing Gu, Lei Cao, Qi Chen, Qing Ye, Guan Yang, Rui-Ting Li, Hang Fan, Yong-Qiang Deng, Xiaopeng Song, Yini Qi, Min Li, Jun Lan, Rui Feng, Yan Guo, Na Zhu, Si Qin, Lei Wang, Yi-Fei Zhang, Chao Zhou, Lingna Zhao, Yuehong Chen, Meng Shen, Yujun Cui, Guan Yang, Xinquan Wang, Wenjie Tan, Hui Wang, Xiangxi Wang, Cheng-Feng Qin
Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2. Nature communications 12 (1) (2021)
Qian-Ying Zhu, Sisi Shan, Jinfang Yu, Si-Ying Peng, Cong Sun, Yanan Zuo, Lan-Yi Zhong, Shu-Mei Yan, Xiao Zhang, Ziqing Yang, Yong-Jian Peng, Xuanling Shi, Su-Mei Cao, Xinquan Wang, Mu-Sheng Zeng, Linqi Zhang
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus. Nature communications 12 (1) (2021)
Wenlin Ren, Yunkai Zhu, Yuyan Wang, Hongyang Shi, Yin Yu, Gaowei Hu, Fei Feng, Xiaomin Zhao, Jun Lan, Jianping Wu, Devin J Kenney, Florian Douam, Yimin Tong, Jin Zhong, Youhua Xie, Xinquan Wang, Zhenghong Yuan, Dongming Zhou, Rong Zhang, Qiang Ding
Comparative analysis reveals the species-specific genetic determinants of ACE2 required for SARS-CoV-2 entry. PLoS pathogens 17 (3) (2021)
Qi Zhang, Bin Ju, Jiwan Ge, Jasper Fuk-Woo Chan, Lin Cheng, Ruoke Wang, Wei Jin Huang, Mengqi Fang, Peng Chen, Bing Zhou, Shuo Song, Sisi Shan, Baohua Yan, Senyan Zhang, Xiangyang Ge, Jiazhen Yu, Juanjuan Zhao, Haiyan Wang, Li Liu, Qining Lv, Lili Fu, Xuanling Shi, Kwok-Yung Yuen, Lei Liu, You-Chun Wang, Zhiwei Chen, Linqi Zhang, Xinquan Wang, Zheng Zhang
Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2. Nature communications 12 (1) (2021)
Renhong Yan, Ruoke Wang, Bin Ju, Jinfang Yu, Yuanyuan Zhang, Nan Liu, Jia Wang, Qi Zhang, Peng Chen, Bing Zhou, Yaning Li, Yaping Shen, Shuyuan Zhang, Long Tian, Yingying Guo, Lu Xia, Xinyue Zhong, Lin Cheng, Xiangyang Ge, Juanjuan Zhao, Hong-Wei Wang, Xinquan Wang, Zheng Zhang, Linqi Zhang, Qiang Zhou
Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies. Cell research 31 (5) (2021)
Xiao-Yan Zhao, Andreas Wilmen, Dongli Wang, Xinquan Wang, Maxine Bauzon, Ji-Yun Kim, Lars Linden, Liang Li, Ursula Egner, Tobias Marquardt, Dieter Moosmayer, Jan Tebbe, Julian Marius Glück, Philipp Ellinger, Kirk McLean, Shujun Yuan, Subramanian Yegneswaran, Xiaoqiao Jiang, Vince Evans, Jian-Ming Gu, Doug Schneider, Ying Zhu, Yifan Xu, Cornell Mallari, Ashley Hesslein, Yan Wang, Nicole Schmidt, Katrin Gutberlet, Christine Ruehl-Fehlert, Alexius Freyberger, Terry Hermiston, Chandra Patel, Derek Sim, Laurent O Mosnier, Volker Laux
Targeted inhibition of activated protein C by a non-active-site inhibitory antibody to treat hemophilia. Nature communications 11 (1) (2020)
Jinfang Yu, Shuyuan Qiao, Runyu Guo, Xinquan Wang
Cryo-EM structures of HKU2 and SADS-CoV spike glycoproteins provide insights into coronavirus evolution. Nature communications 11 (1) (2020)
Jun Lan, Jiwan Ge, Jinfang Yu, Sisi Shan, Huan Zhou, Shilong Fan, Qi Zhang, Xuanling Shi, Qisheng Wang, Linqi Zhang, Xinquan Wang
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581 (7807) (2020)
Bin Ju, Qi Zhang, Jiwan Ge, Ruoke Wang, Jing Sun, Xiangyang Ge, Jiazhen Yu, Sisi Shan, Bing Zhou, Shuo Song, Xian Tang, Jinfang Yu, Jun Lan, Jing Yuan, Haiyan Wang, Juanjuan Zhao, Shuye Zhang, You-Chun Wang, Xuanling Shi, Lei Liu, Jin-Cun Zhao, Xinquan Wang, Zheng Zhang, Linqi Zhang
Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature 584 (7819) (2020)
Sihan Liu, Yanxia Fu, Kunrong Mei, Yinan Jiang, Xiaojun Sun, Yinyin Wang, Fangli Ren, Congshan Jiang, Liesu Meng, Shemin Lu, Zhihai Qin, Chen Dong, Xinquan Wang, Zhijie Chang, Shigao Yang
A shedding soluble form of interleukin-17 receptor D exacerbates collagen-induced arthritis through facilitating TNF-α-dependent receptor clustering. Cellular & molecular immunology 18 (8) (2020)
Yinan Jiang, Xinquan Wang
Structural insights into the species preference of the influenza B virus NS1 protein in ISG15 binding. Protein & cell 10 (9) (2020)
Jiuyang Xu, Wenxu Jia, Pengfei Wang, Senyan Zhang, Xuanling Shi, Xinquan Wang, Linqi Zhang
Antibodies and vaccines against Middle East respiratory syndrome coronavirus. Emerging microbes & infections 8 (1) (2019)

Xinquan Wang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xinquan Wang